AHA and other healthcare related organizations stress the importance of congressional action to lower healthcare premiums.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA letter to Ways and Means Committee regarding policy recommendations to address the opioid epidemic.
AHA responds to the Centers for Medicare Medicaid Services' request for information on revisions to personnel regulations, proficiency testing (PT) referral, histocompatibility regulations, and fee regulations under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.
AHA, others express strong support for the ongoing efforts toward a unified graduate medical education accreditation system, and strongly oppose any legislative attempt to undo the success of this system.
AHA, others urge Congress to move forward with bipartisan legislation to reduce premiums, improve affordability, and improve the individual health insurance market.
AHA, others express concerns that Anthem’s coverage policies for outpatient imaging and emergency care services are detrimental to patients, diminishing access to care and driving care
location based on the lowest cost provider.
AHA's comment on CMS's 2019 Advance Notice and draft Call Letter for 2019.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses
The undersigned groups respectfully request that the Drug Enforcement Administration (DEA)
adjust aggregate production quotas (APQ) for certain opioids in order to mitigate ongoing drug
shortages.